Third Rock Ventures III, L.P.
SEC CIK 1569705 · EDGAR
BoughtSold
Most active insiders at VYGR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Sandrock Alfred | Pres, CEO, Dir | — | $184.4K |
| 2 | Swartz Robin | COO, CBO | — | $55.3K |
| 3 | Jorgensen Nathan D. | CFO | — | $54.2K |
| 4 | Carter Todd Alfred | CSO | — | $40.6K |
| 5 | Shiferman Gregory L. | SVP, GC | — | — |
| 6 | Ferguson Toby | Chief Medical Off | — | — |
Third Rock Ventures III, L.P. made no open-market trades at VYGR in the last 12 months.
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-06 | 2023-02-02 | VYGR | Voyager Therapeutics, Inc. | Third Rock Ventures III, L.P. | 10% | J - Other | — | -1.50M | 3.19M | -32% | — | |
| M | 2023-02-01 | 2023-01-30+ | VYGR | Voyager Therapeutics, Inc. | Third Rock Ventures III, L.P. | 10% | S - Sale | $9.23 | -388.6K | 5.00M | -7% | -$3.59M |
| M | 2023-01-26 | 2023-01-24+ | VYGR | Voyager Therapeutics, Inc. | Third Rock Ventures III, L.P. | 10% | S - Sale | $9.25 | -150.0K | 5.12M | -3% | -$1.39M |
| 2022-12-01 | 2022-11-29 | PLRX | PLIANT THERAPEUTICS, INC. | Third Rock Ventures III, L.P. | 10% | J - Other | — | -2.00M | 1.84M | -52% | — | |
| 2022-09-22 | 2022-09-20 | PLRX | PLIANT THERAPEUTICS, INC. | Third Rock Ventures III, L.P. | 10% | J - Other | — | -2.00M | 3.84M | -34% | — |
Purchase Sale Sale after option exercise All abbreviations